# The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure

> **NCT07482943** · PHASE4 · NOT_YET_RECRUITING · sponsor: **The University of Hong Kong** · enrollment: 30 (estimated)

## Conditions studied

- Fontan
- Heart Failure
- Dapagliflozin
- Cardiovascular Diseases
- Sodium-GLucose coTransporter-2 Inhibitors

## Interventions

- **DRUG:** Dapagliflozin (5-10 mg daily) - SGLT2 Inhibitor Therapy

## Key facts

- **NCT ID:** NCT07482943
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2028-04
- **Final completion:** 2028-04
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07482943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07482943, "The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure". Retrieved via AI Analytics 2026-07-24 from https://api.ai-analytics.org/clinical/NCT07482943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*